Cann American Corp.

CNNA

US13764N2071

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 20:58:20 24/05/2024 BST			5-day change	1st Jan Change
0.0033 ^USD	-5.71%		-17.50%	-17.50%

2023	Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	CI
2023	Cann American Corp. Auditor Raises 'Going Concern' Doubt	CI

Fly Beverage Corp. announced that it expects to receive funding from Cann American Corp.

May 03, 2020

Fly Beverage Corp. announced that it will receive equity investment from new investor Cann American Corp. (OTCPK:CNNA) on May 4, 2020. Current estimates for company's valuation are between $8 million to $11 million.

Latest news about Cann American Corp.

Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	14/06/23	CI
Cann American Corp. Auditor Raises 'Going Concern' Doubt	13/06/23	CI
Cann American Corp. Appoints Michael G. Kramer as a Director	17/05/23	CI
Cann American Corp. completed the acquisition of acquire Liberty Health Plus.	09/05/23	CI
Cann American Corp. entered into a letter of intent to acquire Liberty Health Plus.	30/04/23	CI
Cann American Corp. Appoints Peter Caruso as Director	16/03/23	CI
Cann American Corp. acquired Prodigy Stem Cell, LLC.	15/03/23	CI
Cann American Corp. Announces Board and Executive Changes	06/02/23	CI
Cann American Corp. Announces CEO Changes	06/02/23	CI
Cann American Corp. Reinstates Jason Black as CEO	25/01/23	CI
Cann American Corp. Announces Executive Changes	25/01/23	CI
Cann American Corp. has entered into an additional binding letter of intent to acquire 75% equity in Valkyrie Systems Inc.	08/11/22	CI
Cann American Corp. Appoints Alexander Woods-Leo as CEO	02/11/22	CI
Cann American Corp. Announces Management Changes	02/11/22	CI
Cann American Corp. completed the acquisition of 80% stake in Mark2media Group LLC.	30/10/22	CI
Cann American Corp. entered into a binding letter of intent to acquire 80% stake in Mark2media Group LLC.	25/10/22	CI
Cann American Corp. Accepts the Resignation of Bradley Hanger as Director	24/10/22	CI
Cann American Corp. acquired Hourglass Enterprises LLC.	11/05/21	CI
Fly Beverage Corp. announced that it expects to receive funding from Cann American Corp.	03/05/20	CI
Canamed4Pets, Inc. will Change its Name to Cann American Corp	20/12/19	CI
Cann American Corp. entered into an agreement to acquire Cannequipt, LLC from Patrick King for $0.04 million.	20/10/19	CI
Bioflamex Corporation has Changed its Ticker to BFLXD from BFLX	04/09/14	CI
Bioflamex Corp. Introduces Emergency Escape System	10/09/13	CI
Terra Asset Management, Inc. cancelled the acquisition of Bioflamex Corporation in a reverse merger transaction.	16/10/12	CI
Bioflamex Corporation will Change its Ticker to BFLXE from BFLX	19/06/12	CI

Chart Cann American Corp.

Duration

Period

More charts

Company Profile

Cann American Corp. is a holding company. The Company is engaged in developing assets within the legal cannabis and hemp industries. The Company has two subsidiaries, Cannequipt, LLC and Hourglass Enterprises LLC. Cannequipt, LLC, intends to act as a research and development division. Hourglass Enterprises LLC, intends to focus on developing new assets in the state of Oklahoma. The Company primarily within the state of California.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CANN AMERICAN CORP.	-17.50%	2.43M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B